Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Guangzhou Lupeng Pharmaceutical Company Ltd.

Clinical trials sponsored by Guangzhou Lupeng Pharmaceutical Company Ltd., explained in plain language.

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New drug cocktail aims to tackle tough lymphoma

Disease control Not yet recruiting

This early-stage trial tests a new drug called rocbrutinib combined with standard chemotherapy (R-GemOx) in 42 people with a type of lymphoma (DLBCL) that has returned or not responded to treatment. The main goals are to find a safe dose and see if the combination shrinks tumors.…

Phase: PHASE1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC